Rajendra Kumar, Pradip Mane and Nilesh Atmaram Mali*,
{"title":"Reaction Calorimetry Study of Hydrogenation of Nitroaniline Isomers to Phenylenediamine Isomers","authors":"Rajendra Kumar, Pradip Mane and Nilesh Atmaram Mali*, ","doi":"10.1021/acs.oprd.5c00077","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00077","url":null,"abstract":"<p >In this work, a detailed reaction calorimetry study of hydrogenation of ortho-, meta-, and para- isomers of nitroaniline to the corresponding phenylenediamine isomers was carried out. An automated high-pressure power compensation reaction calorimeter was used in an isothermal mode in the temperature range of 60–150 °C and pressure ranging from 7 to 20 bar. Reactions were performed using heterogeneous palladium- and ruthenium-based catalysts in the presence of solvent. The process safety data comprising heat rate, heat of reaction (Δ<i>H</i>), adiabatic temperature rise (Δ<i>T</i><sub>ad</sub>), maximum temperature of the synthesis reaction (MTSR), and pressure rise in the case of cooling failure were determined for these reactions. The maximum heat rate of the hydrogenation process was found to be 14.30, 27.47, and 10.81 W for ortho-nitroaniline, meta-nitroaniline, and para-nitroaniline, respectively. The heat of reaction was found to be −567.54 kJ/mol, −611.41 kJ/mol, and −555.01 kJ/mol for ortho-nitroaniline, meta-nitroaniline, and para-nitroaniline hydrogenation, respectively. The highest MTSR for all isomers is estimated along with the corresponding pressure rise.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1740–1748"},"PeriodicalIF":3.5,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144807637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yu Qi, Cheng-Cheng Gu, Hao-Xing Xu, Yu-Hong Tao and Xiao Wang*,
{"title":"An Ultrafast Production of Imidazoles at Low Temperature with a 3D-Printed Microflow Reactor","authors":"Yu Qi, Cheng-Cheng Gu, Hao-Xing Xu, Yu-Hong Tao and Xiao Wang*, ","doi":"10.1021/acs.oprd.4c00456","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00456","url":null,"abstract":"<p >At present, imidazoles are predominantly synthesized by the Debus–Radziszewski reaction in batch, a conventional method plagued by issues such as poor selectivity, harsh reaction conditions, and low yield. In this work, a novel continuous-flow process for manufacturing imidazoles has been developed using a specially designed 3D-printed microreactor. This approach offers substantial advantages over the traditional batch synthesis and the existing continuous processes, including higher yields, shorter reaction times, milder conditions, and enhanced scalability. These attributes highlight a potential for industrial-scale production of imidazole and its derivatives, aligning with principles of green chemistry.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1654–1661"},"PeriodicalIF":3.5,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144807662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Naga Lakshmi Ramana Susarla, Dharma Jaganadha Rao Velaga, Mohammed Yakoob Sardar, Anirban Ghosh, Ravi Kumar Gorle, Suhas Jawlekar, Rajeev Rehani Budhdev and Srividya Ramakrishnan*,
{"title":"Continuous Crystallization of Atorvastatin Calcium at a Multitonnage Scale Using Dynamically Mixed Flow Reactors for Target Polymorph Control","authors":"Naga Lakshmi Ramana Susarla, Dharma Jaganadha Rao Velaga, Mohammed Yakoob Sardar, Anirban Ghosh, Ravi Kumar Gorle, Suhas Jawlekar, Rajeev Rehani Budhdev and Srividya Ramakrishnan*, ","doi":"10.1021/acs.oprd.4c00478","DOIUrl":"https://doi.org/10.1021/acs.oprd.4c00478","url":null,"abstract":"<p >At Dr Reddy’s, we have developed an integrated continuous manufacturing process for the generation of atorvastatin calcium drug substance encompassing a series of three reactions, followed by downstream unit operations of crystallization, filtration, and drying. The current work focuses on the design of the continuous crystallization process while integrating with upstream reactions and downstream filtration and minimizing the risk of fouling. The batch process was successfully translated to flow by understanding the critical process parameters and designing a crystallization strategy to achieve the desired polymorph (trihydrate, Form-I) and crystal size distribution. A novel and important feature of the present work is the utilization of Coflore dynamically mixed flow reactors in process development and manufacturing. The ability to achieve excellent macromixing in the dynamically mixed flow reactors irrespective of the flow rates helped in crystal growth with minimal fouling. This enabled better filtration for integration with downstream continuous operations. Overall, a continuous seeded antisolvent plus cooling crystallization process was established with a system consisting of Coflore reactors, followed by three CSTRs in series for a controlled cooling profile to promote uniform crystal growth and maximize yield. This process was successfully demonstrated at lab scale (5.6 g/h) and plant scale (12 kg/h of API output) while seamlessly integrating it within the continuous manufacturing train.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1662–1676"},"PeriodicalIF":3.5,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144807761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kostiantyn Levchenko*, Daria Menshykova and Nazariy Pokhodylo*,
{"title":"New Saturated Bicyclic Pyrrolidines: The Multigram Synthesis and Orthogonal Functionalization","authors":"Kostiantyn Levchenko*, Daria Menshykova and Nazariy Pokhodylo*, ","doi":"10.1021/acs.oprd.5c00135","DOIUrl":"10.1021/acs.oprd.5c00135","url":null,"abstract":"<p >A practical and scalable strategy for the synthesis and functionalization of saturated pyrrolidine-based bicyclic scaffolds has been developed. Starting from commercially available cyclic β-keto esters, a two- or four-step sequence enabled efficient access to condensed 2-pyrrolidones in high yields. Seven structurally distinct bicyclic systems were prepared, each bearing a carboxyl group at the nodal 3a-position, serving as a versatile handle for downstream transformations. Strategic use of orthogonal protecting groups (Bn, Boc, and Cbz) facilitated purification and enabled selective modifications. Curtius rearrangement allowed direct conversion of the carboxylic acid into the corresponding amine, while further diversification included reduction to alcohols, Swern oxidation to aldehydes, mesylation–azidation–reduction, and thiolation–oxidation to sulfonyl chlorides. All transformations were conducted under mild, operationally simple conditions and demonstrated good functional group tolerance. The described methodology provides a robust platform for accessing medicinally relevant pyrrolidine-based bicyclic building blocks and offers practical advantages for application in drug discovery and process chemistry.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1792–1808"},"PeriodicalIF":3.5,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144566505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luca Alessandro Perego, Seppe Hermans, Matthew P. Mower*, Alexander Zhdanko*, Simon Wagschal* and Sébastien Lemaire,
{"title":"Practical Synthesis of 3-Substituted Pyrimidin-4-ones and 4(3H)-Quinazolinones from Nitriles: Mechanistic Insights, Scope, and Scale-Up","authors":"Luca Alessandro Perego, Seppe Hermans, Matthew P. Mower*, Alexander Zhdanko*, Simon Wagschal* and Sébastien Lemaire, ","doi":"10.1021/acs.oprd.5c00124","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00124","url":null,"abstract":"<p >Pyrimidin-4-ones and (3<i>H</i>)-quinazolin-4-ones are widely occurring heterocyclic motifs found in biologically active substances. This report presents a practical and scalable three-step, two-pot synthesis of 2-unsubstituted-3-alkyl/aryl derivatives of these heteroaromatics. During the mechanistic investigation of the hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU)-mediated coupling of 4-hydroxyquinazolines with amines, we found that the <i>N</i>-activated heterocycle underwent nucleophilic attack on the methine atom with subsequent ring opening and ring closing (ANRORC mechanism). Building on the new mechanistic insight, we designed and developed an efficient synthesis of 2-unsubstituted-3-substituted pyrimidin-4-ones through the condensation of β-aminoacrylates with dimethylformamide dimethylacetal (DMF-DMA), followed by cyclization with primary amines. The required β-aminoacrylates were easily obtained in a single step via ZnCl<sub>2</sub>-mediated decarboxylative Blaise–Reformatsky reaction of nitriles, which was extended to aliphatic substrates using an improved protocol. The methodology described herein is particularly suited to execution on a large scale as it requires no chromatography, utilizes no solvents of very high concern, and has been successfully demonstrated on the liter scale.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1775–1787"},"PeriodicalIF":3.5,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144807512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah Nguyen, Wei Wu, Rita C. Barral, Rajshree Chakrabarti, Qinglin Su, Youhua Li, Anjana Ramnath, Bhavya Singh, Ke Wen, Yazid Al Khatib, Khrystyna Shvedova, Stephen C. Born, Chuntian Hu*, Bayan Takizawa, Paul Stonestreet, Michael Berg and Salvatore Mascia*,
{"title":"Process Development for Continuous Manufacturing of Baloxavir Marboxil. Part 1: Step 1 Synthesis","authors":"Hannah Nguyen, Wei Wu, Rita C. Barral, Rajshree Chakrabarti, Qinglin Su, Youhua Li, Anjana Ramnath, Bhavya Singh, Ke Wen, Yazid Al Khatib, Khrystyna Shvedova, Stephen C. Born, Chuntian Hu*, Bayan Takizawa, Paul Stonestreet, Michael Berg and Salvatore Mascia*, ","doi":"10.1021/acs.oprd.5c00156","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00156","url":null,"abstract":"<p >Annually, influenza viruses have a substantial impact on global health, often resulting in severe illness and death. While influenza vaccines are accessible, antiviral medications, such as baloxavir marboxil (marketed as Xofluza), play a vital role in both postexposure prevention and treatment, specifically targeting seasonal influenza A and influenza B. The Step 1 synthesis of baloxavir marboxil is from S199AL to S-033447 and includes four unit operations (i.e., reactive crystallization to S-033447·CSA (camphorsulfonic acid), continuous rotary filtration of S-033447·CSA, neutralization and purification of S-033447·CSA to S-033447, and continuous rotary filtration of S-033447). S-033447·CSA was formed from S199AL and S199AR through a continuous reactive crystallization in a 500 mL five-stage CSTR cascade. The solid yield was 66.2% with a residence time of 28 h. The neutralization of S-033447·CSA and crystallization of S-033447 were performed in a two-stage MSMPR cascade. A pH probe was located in the first stage (i.e., neutralization stage), and a ReactIR probe was placed in the second stage (i.e., crystallization stage) to monitor the antisolvent addition. The crystallization yield was 91–93% for a 65% water volume fraction. The filtration processes of S-033447·CSA and S-033447 slurry were conducted with a continuous rotary filter, and steady state was achieved.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1857–1868"},"PeriodicalIF":3.5,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144806768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hao Wu*, Xu Ma, Joe Ju Gao, Jose Santiago-Rivera, Clement Valentin, Jon C. Lorenz, Xiaole Shao, Jing Liu and Frederic Buono,
{"title":"Biocatalytic Synthesis of (R)-3-Aminotetrahydropyran through a Direct Transamination at Kilogram Scale","authors":"Hao Wu*, Xu Ma, Joe Ju Gao, Jose Santiago-Rivera, Clement Valentin, Jon C. Lorenz, Xiaole Shao, Jing Liu and Frederic Buono, ","doi":"10.1021/acs.oprd.5c00142","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00142","url":null,"abstract":"<p >Chiral amines with a low molecular weight are useful intermediates in the synthesis of active pharmaceutical ingredients (APIs). Here, we present a scalable one-step synthesis of (<i>R</i>)-3-aminotetrahydropyran through a straightforward biocatalytic transamination (vs previous five-step synthesis). The product was isolated by direct precipitation of salt without the need for organic solvent extraction or chromatography. The highlights of this process include differentiation of the two enantiotopic faces of the ketone substrate via a biocatalyst as well as providing a solution to isolate the reasonably volatile product directly from reaction mixture. The process was optimized using design of experiment (DoE) principle combined with enzyme kinetic studies and successfully demonstrated at kilogram scale, achieving 53% isolation yield and an enantiomeric ratio of 96:4 of the amine product.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1822–1830"},"PeriodicalIF":3.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144805806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rita C. Barral, Hannah Nguyen, Rajshree Chakrabarti, Bhavya Singh, Wei Wu, Shalabh S. Yeole, Youhua Li, Anjana Ramnath, Uma Raul, Aibolat Koishybay, Taryn Sparacino, Michael Stamm, Chuntian Hu*, Bayan Takizawa, Paul Stonestreet, Michael Berg and Salvatore Mascia*,
{"title":"Process Development for Continuous Manufacturing of Baloxavir Marboxil. Part 2: Step 2 Synthesis","authors":"Rita C. Barral, Hannah Nguyen, Rajshree Chakrabarti, Bhavya Singh, Wei Wu, Shalabh S. Yeole, Youhua Li, Anjana Ramnath, Uma Raul, Aibolat Koishybay, Taryn Sparacino, Michael Stamm, Chuntian Hu*, Bayan Takizawa, Paul Stonestreet, Michael Berg and Salvatore Mascia*, ","doi":"10.1021/acs.oprd.5c00157","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00157","url":null,"abstract":"<p >The pharmaceutical manufacturing sector is steadily transitioning from batch to continuous operations, as the drawbacks of batch operations and the advantages of continuous operations have increasingly provided compelling motivation for change. This study, which details the Step 2 synthesis of baloxavir marboxil (from S-033447 to S-033188), provides an example of how continuous manufacturing implementation can offer significant operational benefits. The process includes four unit operations (i.e., reaction to S-033188, crystallization and purification of S-033188, continuous rotary filtration of S-033188, and continuous wet milling and drying of S-033188). S-033188 was formed in a three-stage 500 mL CSTR cascade with a ReactIR in the third stage. The total residence time was 10.5 h, and the high-performance liquid chromatography (HPLC) area% of S-033188 and S-033447 in the third stage was 96.6 and 0.6%, respectively. The continuous crystallization of S-033188 was performed in a three-stage MSMPR system, and the crystallization yield was 97.1% with a 15-fold antisolvent addition. Focused beam reflectance measurement (FBRM) was located in the third stage to monitor the start-up and steady state during the run. A continuous rotary filter was used to process the S-033188 slurry, and it operated with a vacuum pressure of approximately −15 kPa and a cake height of 4 mm after reaching a steady state. Wet milling was applied to achieve the required quality attribute of S-033188 on particle size distribution (PSD), and heptane/ethyl acetate (50:1, v/v) was selected as the resuspension solvent. After wet milling, S-033188 was dried with a continuous drum dryer, resulting in desired Form I.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1843–1856"},"PeriodicalIF":3.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144805958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rocco Bussolati*, Paolo Ronchi*, Fausto Pivetti, Claudio Fiorelli, Emanuele Ferrari, Diego Copelli, Massimiliano Mari, Paolo Bruno, Matteo Biagetti, Piotr Malysa, Xiaoping Tang, Jonathan Simmons, Max Espensen, Benjamin Rowley, Peter Mullens, Huihua Lu, Junqiang Wang, Huajun Ge and Zhongwei Zhang,
{"title":"Optimizing the CHF6523 Isocoumarin Core Scaffold: From the Preclinical Stage to Large-Scale Production","authors":"Rocco Bussolati*, Paolo Ronchi*, Fausto Pivetti, Claudio Fiorelli, Emanuele Ferrari, Diego Copelli, Massimiliano Mari, Paolo Bruno, Matteo Biagetti, Piotr Malysa, Xiaoping Tang, Jonathan Simmons, Max Espensen, Benjamin Rowley, Peter Mullens, Huihua Lu, Junqiang Wang, Huajun Ge and Zhongwei Zhang, ","doi":"10.1021/acs.oprd.5c00133","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00133","url":null,"abstract":"<p >The structure of the new active pharmaceutical ingredient (API) PI3Kδ inhibitor CHF6523.02, identified for the treatment of exacerbating chronic obstructive pulmonary disease (COPD) in patients, is reported. The described molecule bears an isocoumarin core scaffold, whose synthetic route scalability is critical for API process development and the successful establishment of a multikilogram synthesis route. In this paper, we describe the process research and development work for the isocoumarin scaffold synthetic procedure, exploiting a novel and efficient electrophilic cyclization step, to provide large quantities of the product required to support the API candidate’s clinical studies.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1809–1821"},"PeriodicalIF":3.5,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144808850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hao Li, Jin-Xi Wu, Guang-Yuan Zhang, Ning-Ning Du, Le-Wu Zhan, Jing Hou* and Bin-Dong Li*,
{"title":"Correction to “Thermal Hazard Assessment of the Synthesis of 1,1′-Azobis-1,2,3-triazole”","authors":"Hao Li, Jin-Xi Wu, Guang-Yuan Zhang, Ning-Ning Du, Le-Wu Zhan, Jing Hou* and Bin-Dong Li*, ","doi":"10.1021/acs.oprd.5c00169","DOIUrl":"https://doi.org/10.1021/acs.oprd.5c00169","url":null,"abstract":"","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"29 7","pages":"1869–1872"},"PeriodicalIF":3.5,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144808999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}